Literature DB >> 33393507

Interferons in cancer immunoediting: sculpting metastasis and immunotherapy response.

Michelle von Locquenghien, Catalina Rozalén, Toni Celià-Terrassa.   

Abstract

Interferons (IFNs) are pleiotropic cytokines critical for regulation of epithelial cell functions and for immune system regulation. In cancer, IFNs contribute to tumor-intrinsic and -extrinsic mechanisms that determine the quality of antitumor immunity and response to immunotherapy. In this Review, we focus on the different types of tumor IFN sensitivity that determine dynamic tumor-immune interactions and their coevolution during cancer progression and metastasis. We extend the discussion to new evidence supporting immunotherapy-mediated immunoediting and the dual opposing roles of IFNs that lead to immune checkpoint blockade response or resistance. Understanding the intricate dynamic responses to IFN will lead to novel immunotherapeutic strategies to circumvent protumorigenic effects of IFN while exploiting IFN-mediated antitumor immunity.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33393507      PMCID: PMC7773346          DOI: 10.1172/JCI143296

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  186 in total

1.  A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing.

Authors:  Deng Pan; Aya Kobayashi; Peng Jiang; Lucas Ferrari de Andrade; Rong En Tay; Adrienne M Luoma; Daphne Tsoucas; Xintao Qiu; Klothilda Lim; Prakash Rao; Henry W Long; Guo-Cheng Yuan; John Doench; Myles Brown; X Shirley Liu; Kai W Wucherpfennig
Journal:  Science       Date:  2018-01-04       Impact factor: 47.728

Review 2.  Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy.

Authors:  Padmanee Sharma; Siwen Hu-Lieskovan; Jennifer A Wargo; Antoni Ribas
Journal:  Cell       Date:  2017-02-09       Impact factor: 41.582

Review 3.  Cancer Genome Evolutionary Trajectories in Metastasis.

Authors:  Nicolai J Birkbak; Nicholas McGranahan
Journal:  Cancer Cell       Date:  2020-01-13       Impact factor: 31.743

4.  Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.

Authors:  Ayumi Satoh; Minoru Toyota; Hideyuki Ikeda; Yoshikazu Morimoto; Kimishige Akino; Hiroaki Mita; Hiromu Suzuki; Yasushi Sasaki; Takayuki Kanaseki; Yukio Takamura; Hidenobu Soejima; Takeshi Urano; Kazuyoshi Yanagihara; Takao Endo; Yuji Hinoda; Masahiro Fujita; Masao Hosokawa; Noriyuki Sato; Takashi Tokino; Kohzoh Imai
Journal:  Oncogene       Date:  2004-11-25       Impact factor: 9.867

5.  Discrepant effects of interferon murine syngeneic ascites tumors and their solid metastasizing counterparts.

Authors:  W Ryd; B Hagmar; E Lundgren; O Strannegård
Journal:  Int J Cancer       Date:  1979-03-15       Impact factor: 7.396

6.  Transcriptional induction by interferon. New protein(s) determine the extent and length of the induction.

Authors:  A C Larner; A Chaudhuri; J E Darnell
Journal:  J Biol Chem       Date:  1986-01-05       Impact factor: 5.157

7.  LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade.

Authors:  Wanqiang Sheng; Martin W LaFleur; Thao H Nguyen; Sujun Chen; Ankur Chakravarthy; Jake Ryan Conway; Ying Li; Hao Chen; Henry Yang; Pang-Hung Hsu; Eliezer M Van Allen; Gordon J Freeman; Daniel D De Carvalho; Housheng Hansen He; Arlene H Sharpe; Yang Shi
Journal:  Cell       Date:  2018-06-21       Impact factor: 41.582

Review 8.  IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance.

Authors:  David H Munn; Andrew L Mellor
Journal:  Trends Immunol       Date:  2016-01-31       Impact factor: 16.687

Review 9.  Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.

Authors:  Robert D Schreiber; Lloyd J Old; Mark J Smyth
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

10.  Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis.

Authors:  Michele De Palma; Roberta Mazzieri; Letterio S Politi; Ferdinando Pucci; Erika Zonari; Giovanni Sitia; Stefania Mazzoleni; Davide Moi; Mary Anna Venneri; Stefano Indraccolo; Andrea Falini; Luca G Guidotti; Rossella Galli; Luigi Naldini
Journal:  Cancer Cell       Date:  2008-10-07       Impact factor: 31.743

View more
  6 in total

Review 1.  Targeting Cancer Stem Cells through Epigenetic Modulation of Interferon Response.

Authors:  Jau-Ling Huang; Si-Yun Chen; Chang-Shen Lin
Journal:  J Pers Med       Date:  2022-04-01

Review 2.  Polysaccharide-based nanomedicines for cancer immunotherapy: A review.

Authors:  Yujun Zeng; Yufan Xiang; Ruilong Sheng; Helena Tomás; João Rodrigues; Zhongwei Gu; Hu Zhang; Qiyong Gong; Kui Luo
Journal:  Bioact Mater       Date:  2021-03-18

Review 3.  TRIMming Type I Interferon-Mediated Innate Immune Response in Antiviral and Antitumor Defense.

Authors:  Ling Wang; Shunbin Ning
Journal:  Viruses       Date:  2021-02-11       Impact factor: 5.818

4.  High expression of lncRNA HSD11B1-AS1 indicates favorable prognosis and is associated with immune infiltration in cutaneous melanoma.

Authors:  Kaiyuan Liu; Li Zhang; Xiuli Li; Jingjun Zhao
Journal:  Oncol Lett       Date:  2021-12-20       Impact factor: 2.967

Review 5.  Current landscape and perspective of oncolytic viruses and their combination therapies.

Authors:  Yinghan Su; Changqing Su; Lunxiu Qin
Journal:  Transl Oncol       Date:  2022-09-09       Impact factor: 4.803

6.  Single-cell dissection of remodeled inflammatory ecosystem in primary and metastatic gallbladder carcinoma.

Authors:  Xiang Wang; Chunliang Liu; Jianan Chen; Lei Chen; Xianwen Ren; Minghui Hou; Xiuliang Cui; Youhai Jiang; Erdong Liu; Yali Zong; Anqi Duan; Xiaohui Fu; Wenlong Yu; Xiaofang Zhao; Zhao Yang; Yongjie Zhang; Jing Fu; Hongyang Wang
Journal:  Cell Discov       Date:  2022-10-05       Impact factor: 38.079

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.